This is a mobile optimized page that loads fast, if you want to load the real page, click this text.

ACR - Acrux Limited

Jump to new
Re: ACR - Acrux

Yeah Gurgler I still have this on my watchlist.

To me it looks like an ugly head and shoulders fromation, which i believe isn't a very good sign.
Ive noticed that the multiple moving averages are all travelling downwards too.
I too still think that this is a great company though. It always gets a mention in the Biostock newsletter that Kennas kindly forwards too me.

Hang in there mate. Gues it might just be turning from a trade to a "longer term investment"
 
Re: ACR - Acrux

I see Ross Dobinson (director) sold all his shares (9.20% of market cap) as a result of Opes Prime...this may have been the good buying opportunity supporters were waiting for
 
Re: ACR - Acrux

Commences phase 3 trial of testosterone md lotion vetinary phase 3 trial. Roadshow commences in July. Chairman buys back 3.3million shares taken by ANZ. Spoke to directors last week and sounded bullish with more news coming in and revenue. Up 25% last week.
 
Re: ACR - Acrux

Bit of a retrace underway, but still optimistic on this stock, given Phase 3 trials well underway:

Today's FN Arena:

Acrux A Standout Life Science Play
FN Arena News - July 02 2008
By Chris Shaw

Excerpts:
... according to ABN Amro Morgans Acrux (ACR) is one such stock, the broker seeing the company as a standout in the sector and initiating coverage on the company with a Buy rating .....

... the product is targeting a market worth around US$1.4 billion and given the company has a solid partner in KV Pharmaceuticals there is hope peak annual sales can grow to something in the order of US$125 million .....

.... the broker expects group revenue will grow to around $3.8 million this year, $6.3 million in FY09 and $19.5 million in FY10, which in that year would translate into a profit of around $8.1 million......

The broker values the stock at $2.09 and has set its price target at this level, which implies significant upside given the stock is currently trading at around the $1.20 level.
 
Re: ACR - Acrux

yeah breaking above $1 was really positive for this stock.

I'd go as far as to say its now in an uptrend.

Its all on low volume though with this company. but then again CXS is a bio that trends up well on low volume.

Goodluck to those that hold
 
Re: ACR - Acrux

I'd have to say this is definitely a Buy has been for sometime I think.

Chart is trending up nicely and brokers have had a buy on this stock for ages.

Bit of resistance to get through coming up, but it might just bounce between $1.30 and $1.40 if it gets there.

(I don't hold any ACR)
 
Re: ACR - Acrux



Hm not too bad

Earnings and Dividends Forecast (cents per share)
2007 2008 2009 2010
EPS -5.7 -3.7 -3.5 15.3
DPS 0.0 0.0 0.0 0.0

Business Description
Acrux Limited is a pooled development fund investing in pharmaceutical products intended to enable safe and effective delivery of a broad range of drugs through the skin known as transdermal drug delivery. ACR holds IP to transdermal drug delivery technology platform made up of Across Enhancers, MDTS and the Patchless Patch.



thx

MS
 
Re: ACR - Acrux

I'm an Acrux fan - I bought in at the IPO in 1999 and have held my shares ever since. New positive announcement today - here are some excerpts:

ACRUX REPORTS POSITIVE RESULTS OF US PHYSICIAN MARKET RESEARCH ON TESTOSTERONE MD-LOTION ®

91% of physicians surveyed in the US rated Testosterone MD-Lotion as very good or excellent in being able to improve the patient experience, compared with existing gel treatments 87% of physicians said they would offer Testosterone MD-Lotion to their existing gel patients

Acrux CEO Richard Treagus said “This positive endorsement of Testosterone MD-Lotion by a cross section of US physicians complements the strong patient preference already shown by our previous research. This provides the clearest indicator yet of the potential for the Acrux product to capture a significant share of the US$900 million testosterone therapy market”.
 
Re: ACR - Acrux

Anyone got any ideas as to the trading halt?

How much cash have they got? Capital raising.....or possible partnership I wonder.

My internet has been capped from excess usage (for 2 more days anyway), so browsing newswebsites with heaps of ads etc is impossible when you have been limited to about 6kbs
 
Re: ACR - Acrux

Something's up here - anyone with any biotech insight?

Gone from 48 to 69 today - that's 43% without any announcement; speeding ticket on the way!
 
Re: ACR - Acrux

7.2+ Mil shares got XTOS'd this morning.

Perhaps an insto taking a position in ACR.
I haven't really been following shares too closly lately.
Its been a bit depressing and so my interest has lost its way
 
Re: ACR - Acrux

Interesting movement in the past couple of months.

Could this mainly be related to their Phase 3 trial for Testosterone MD-Lotion ®, which is now re-named under the AXIRON brand (see attached)?

Any upward movement is welcome of course, as long as it can be sustained!
 

Attachments

  • ACR 11 May.gif
    8.6 KB · Views: 146
  • ACR Announcement=20090422.pdf
    501.4 KB · Views: 9
Re: ACR - Acrux

Have been watching this one for a while myself and was about to make a post too.

Does seem to have come along nicely over the last couple months, while the last two days have certainly been standouts. Greater gains and volume for this small stock.

While you probably couldn't call 0.70 a resistance level, it has certainly shot through the most recent high.
 
Re: ACR - Acrux

matty193 said:
While you probably couldn't call 0.70 a resistance level, it has certainly shot through the most recent high.
Click to expand...

Shot through 80 as well today. In answer to the ASX speeding ticket query, ACR responded:

Overnight on Thursday 7 May, the US Food and Drug Administration (FDA) announced that it is requiring manufacturers of two prescription topical testosterone gel products, AndroGel ® and Testim ®, to include a boxed warning on the products’ labels. The FDA is requiring this action after receiving reports of adverse effects in children who were inadvertently exposed to testosterone through contact with another person being treated with these products (secondary exposure). The required label changes will provide additional information about the risk of secondary exposure and the steps that should be taken to reduce this risk. AndroGel ® and Testim ®, which are approved for use in men who either no longer produce testosterone or produce it in very low amounts, are the principal competitor products in the market targeted by Acrux’s product AXIRON™, which is nearing the end of Phase 3 trials. One of a number of advantages of AXIRON™ compared with these products is a reduced risk of secondary exposure.
 
Re: ACR - Acrux

Still following this stock I see Gurgler.

Do you hold this stock?

Ive watched it for years and was amazed to see how much it has taken off recently.
Undoubtably it would be in aticipation of the phase 3 resluts due soon.

Well done to those that have held onto this stock from its highs. The rewards may be nearing for you

ps I do not hold this stock.
 
Re: ACR - Acrux

bought into this company because i really like what they are developing

Hormone replacement therapy and contraception are two areas that have massive markets that will continue to grow in time
they have multiple products already generating some sales with others still at testing stage
a read of their quarterly newsletter is encouraging
their shares continue to climb a few % each day
 
Re: ACR - Acrux

Go Nuke said:
Still following this stock I see Gurgler.

Do you hold this stock?
Click to expand...

Yes, GN still in there and intending to stay the distance. The products that this stock possesses augur well for ongoing positive movement. As you can see there has been consistent volume over the past month.

Does this bode well for continued growth or does it prempt a retracement? Time (and the market) will tell.
 

Attachments

  • ACR 1 June 09.gif
    8.6 KB · Views: 101
Re: ACR - Acrux

Wow...cant believe there are no new posts here!!!!

Acrux has gone bluesky!!

I should have bought on the breakout above $1.70. Looks great today!

One of the first stocks I stated watching...but yet never owned.
Too late too, as I bought CXS today, as I think its ready for another break upwards.

Cant be in everything I suppose.

Congrats Gurges:>
 

Attachments

  • ACR.jpg
    80.2 KB · Views: 5
You must log in or register to reply here.
Menu
Log in
Register
Cookies are required to use this site. You must accept them to continue using the site. Learn more...